What is the long road to an answer costing you?
In the US, women’s specialty care is billed as a journey — multiple visits, repeat workups, top-tier billing codes — before anyone gets an answer. Estimate what that costs your organization, and what a direct path looks like.
Your organization
US average: $17,496 (Mercer, 2025)
Estimate mode
Conservative uses lower symptom-prevalence, care-seeking, and productivity assumptions.
Your estimated annual exposure
$265,016
across 350 women aged 40–60 in your workforce
Redundant diagnostic claims
extra E/M visits, repeat specialist workups, duplicate labs
$70,875
Absenteeism
Mayo Clinic: ~11% miss ≥1 workday/yr from symptoms
$30,078
Presenteeism
reduced productivity while at work (modeled)
$105,000
Attrition
replacement at 1.5x salary (modeled)
$59,063
Status quo exposure
$265,016
Blair investment (scoped rollout)
$150,000
Estimated return
$0.62
for every $1 invested, assuming Blair mitigates 35% of exposure in year one.
Methodology & sources: Estimates modeled from published research: Mayo Clinic Proceedings (menopause symptoms cost US employers $1.8B/yr in lost work time; $26.6B including medical expenses; 13% of women 45–60 report adverse work outcomes; ~11% miss ≥1 workday/yr) · national survey data (~40% of women report perimenopause misdiagnosis) · commercial E/M reimbursement benchmarks (new-patient specialist visits, CPT 99204–99205: $215–395+) · Mercer National Survey of Employer-Sponsored Health Plans (avg $17,496/employee, 2025). Presenteeism and attrition figures are modeled estimates, not measured outcomes; assumptions shown are adjustable. This tool provides directional estimates for planning purposes and does not constitute actuarial, financial, or clinical advice.